| Literature DB >> 31666068 |
Josef Marek1, Jean-Claude Lubanda1, Renata Cifkova1,2, Petr Kuchynka1, Lubor Golan1, Eduard Nemcek1, Ales Linhart3.
Abstract
BACKGROUND: Normative reference values for echocardiographic chamber quantification are of great importance; however, this can be challenging. Our aim was to derive these values including degrees of abnormality from a random Central European population sample with a homogeneous subset of healthy subjects.Entities:
Keywords: Atrium; Echocardiography; Left ventricular end-diastolic dimension; Left ventricular function; Left ventricular mass; Right ventricular function
Mesh:
Year: 2019 PMID: 31666068 PMCID: PMC6822480 DOI: 10.1186/s12947-019-0172-0
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Fig. 1Flowchart showing selection of patients for the present study. The population was randomly selected from the country’s three districts as part of the Czech post-MONICA study 2007–2008. CV, Cardiovascular. The numbers in parentheses indicate amount of patients that were excluded for that specific reason
Fig. 2Illustration showing definition of reference ranges. Upper part of the figure shows distribution in healthy individuals, with the 95th quantile used to define abnormal value. Lower part of the figure shows the ways for defining different degrees of abnormality. Patients falling above the 95th percentile of the healthy population but under the 97.5th percentile of the general population were classified as mildly abnormal; those between the 97.5th and 99th percentiles of the general population as moderately abnormal and patients over the 99th percentile of the general population as severely abnormal. The actual distribution density of this illustration was based on LV atrial volume distribution in males (indexed to BSA). BSA, body surface area; LV, left ventricle
Baseline characteristics
| Variable | Healthy subset | Remaining cohort | |
|---|---|---|---|
| Age (years) | 42 [34, 52] | 58 [49, 65] | < 0.001 |
| Female gender, n (%) | 328 (57%) | 631 (49%) | 0.003 |
| BSA (m2) | 1.82 [1.70, 1.99] | 1.97 [1.82, 2.13] | < 0.001 |
| Weight (kg) | 72 [62, 81] | 86 [74, 98] | < 0.001 |
| Height (cm) | 171 [165, 179] | 171 [163, 177] | 0.003 |
| BMI (kg/m2) | 24 [22, 26] | 29 [26, 33] | < 0.001 |
| Systolic blood pressure (mmHg) | 118 [109, 124] | 132 [121, 144] | < 0.001 |
| Diastolic blood pressure (mmHg) | 78 [72, 81] | 83 [78, 90] | < 0.001 |
| History of CVD, n (%) | 230 (18%) | ||
| Antihypertensive medication, n (%) | 606 (48%) | ||
| Diabetes mellitus, n (%) | 171 (13%) | ||
| Lipid-lowering drugs, n (%) | 298 (23%) | ||
| Total serum cholesterol (mmol/l) | 5.02 [4.42, 5.71] | 5.25 [4.57, 5.92] | < 0.001 |
| Total serum triglycerides (mmol/l) | 0.97 [0.73, 1.39] | 1.39 [1.03, 2.02] | < 0.001 |
| HDL cholesterol (mmol/l) | 1.51 [1.27, 1.76] | 1.34 [1.10, 1.62] | < 0.001 |
| LDL cholesterol (mmol/l) | 2.94 [2.37, 3.58] | 3.05 [2.41, 3.65] | 0.091 |
| Age group (n) | < 0.001 | ||
| under 40 years | 239 | 160 | |
| 40–60 years | 283 | 556 | |
| over 60 years | 53 | 559 |
Continuous variables presented as median [25th, 75th percentile]
BMI body mass index, BSA body surface area, CVD cardiovascular disease
Effects of age and gender on reference limits – left ventricle
| Variable | Age effect (per 10 years) | Age effect | Gender effect (male vs. female) | Gender effect |
|---|---|---|---|---|
| Left ventricular dimensions | ||||
| 2D method | ||||
| LV end-diastolic diameter (mm) | −0.7 [−1.0, − 0.3] | 0.001 | 5.6 [4.3, 7.0] | < 0.001 |
| LV end-diastolic diameter, BSA (mm/m2) | −0.4 [− 0.8, − 0.1] | 0.021 | − 1.4 [− 2.5, − 0.4] | 0.007 |
| M-mode method | ||||
| LV end-diastolic diameter (mm) | 0.5 [− 0.1, 1.2] | 0.113 | 5.4 [4.0, 6.8] | < 0.001 |
| LV end-diastolic diameter, BSA (mm/m2) | 0.3 [−0.1, 0.7] | 0.107 | −1.3 [−2.1, − 0.4] | 0.004 |
| LV end-systolic diameter (mm) | 0.7 [− 0.2, 1.6] | 0.114 | 4.1 [1.9, 6.2] | < 0.001 |
| LV end-systolic diameter, BSA (mm/m2) | 0.4 [−0.1, 0.9] | 0.109 | −0.4 [−1.5, 0.7] | 0.469 |
| LV mass and wall thickness | ||||
| 2D method | ||||
| Interventricular septum (mm) | 0.5 [0.1, 0.8] | 0.011 | 1.3 [0.4, 2.3] | 0.004 |
| LV Posterior wall (mm) | 0.4 [0.2, 0.6] | < 0.001 | 1.5 [1.0, 2.0] | < 0.001 |
| LV mass, BSA (g/m2) | 4.2 [2.1, 6.4] | < 0.001 | 23.5 [18.4, 28.6] | < 0.001 |
| M-mode method | ||||
| Interventricular septum (mm) | 0.6 [0.3, 0.9] | < 0.001 | 1.7 [0.9, 2.5] | < 0.001 |
| LV Posterior wall (mm) | 0.6 [0.4, 0.8] | < 0.001 | 1.6 [1.1, 2.0] | < 0.001 |
| LV mass, BSA (g/m2) | 7.1 [3.2, 11.1] | < 0.001 | 22.6 [10.6, 34.5] | < 0.001 |
| LV mass, height2.7 (g/m) | 4.2 [2.2, 6.2] | < 0.001 | 4.8 [−0.2, 9.8] | 0.060 |
| LV volumes and function | ||||
| LV end-diastolic volume (ml) | −6.6 [− 10.0, −3.1] | < 0.001 | 35.4 [25.1, 45.6] | < 0.001 |
| LV end-diastolic volume, BSA (ml/m2) | −3.1 [− 6.5, 0.4] | 0.081 | 8.4 [0.9, 16.0] | 0.029 |
| LV end-systolic volume (ml) | −3.6 [−5.0, −2.1] | < 0.001 | 23.2 [19.4, 27.0] | < 0.001 |
| LV end-systolic volume, BSA (ml/m2) | −2.1 [−3.5, − 0.8] | 0.002 | 6.4 [2.9, 9.9] | < 0.001 |
| LV ejection fraction (%) | 1.4 [− 0.1, 2.9] | 0.059 | − 1.6 [−5.7, 2.6] | 0.455 |
| Mitral septal s’ (cm/s) | − 0.2 [− 0.4, − 0.1] | 0.001 | −0.1 [− 0.4, 0.3] | 0.658 |
| Mitral lateral s’ (cm/s) | − 0.3 [− 0.5, − 0.1] | 0.002 | 0.4 [− 0.1, 0.8] | 0.162 |
Values depict effect size on reference limit (95th or 5th percentile of the healthy subset) with 95% confidence interval
BSA body surface area, LV left ventricle
Effects of age and gender on reference limits – left atrium, right chambers, aorta
| Variable | Age effect (per 10 years) | Age effect | Gender effect (male vs. female) | Gender effect |
|---|---|---|---|---|
| Left atrium | ||||
| LA diameter M-mode (mm) | 0.7 [− 0.2, 1.7] | 0.138 | 4.3 [2.1, 6.6] | < 0.001 |
| LA diameter M-mode, BSA (mm/m2) | 1.0 [0.5, 1.4] | < 0.001 | − 1.3 [− 2.2, − 0.3] | 0.009 |
| LA vertical diameter (mm) | −0.2 [− 1.4, 1.0] | 0.752 | 4.2 [0.2, 8.2] | 0.042 |
| LA horizontal diameter (mm) | 1.1 [−0.0, 2.3] | 0.056 | 1.6 [−1.0, 4.2] | 0.232 |
| LA volume (ml) | 1.1 [−2.7, 5.0] | 0.571 | 15.4 [4.0, 26.9] | 0.008 |
| LA volume, BSA (ml/m2) | 1.6 [−0.3, 3.5] | 0.097 | 0.2 [−4.8, 5.3] | 0.924 |
| Right ventricle | ||||
| RV basal diameter (mm) | 0.9 [−0.2, 1.9] | 0.109 | 6.9 [3.7, 10.0] | < 0.001 |
| RV basal diameter, BSA (mm/m2) | 0.4 [−0.0, 0.9] | 0.066 | 0.1 [−1.0, 1.2] | 0.839 |
| Tricuspid s’ (m/s) | −0.2 [− 0.6, 0.2] | 0.261 | − 0.7 [− 1.6, 0.3] | 0.194 |
| TAPSE (mm) | − 0.6 [− 1.5, 0.2] | 0.144 | −0.0 [−2.3, 2.2] | 0.992 |
| Right atrium | ||||
| RA vertical diameter (mm) | −0.0 [− 0.7, 0.7] | 1.000 | 5.7 [4.1, 7.3] | < 0.001 |
| RA horizontal diameter (mm) | −0.5 [−1.4, 0.3] | 0.202 | 6.3 [4.3, 8.3] | < 0.001 |
| RA vertical diameter, BSA (mm/m2) | 0.6 [0.1, 1.0] | 0.009 | −1.6 [−2.4, −0.8] | < 0.001 |
| RA horizontal diameter, BSA (mm/m2) | 0.1 [−0.4, 0.6] | 0.663 | −0.5 [−1.8, 0.8] | 0.443 |
| Aorta | ||||
| Aortic root (mm) | 0.8 [−0.1, 1.8] | 0.084 | 5.5 [3.4, 7.7] | < 0.001 |
| Aortic root, BSA (mm/m2) | 0.4 [0.0, 0.8] | 0.045 | −0.3 [−1.2, 0.7] | 0.589 |
Values depict effect size on reference limit (95th or 5th percentile of the healthy subset) with 95% confidence interval
BSA body surface area, LA left atrium, RA right atrium, RV right ventricle, TAPSE tricuspid annular plane systolic excursion
Fig. 3This image in parasternal long-axis view illustrates some limitations of the M-mode method of measuring LV dimension and wall thickness in some patients. In the M-mode image on the left, an oblique cut leads to multiple problems. First is incorrect measurement of interventricular septum and possible confounding from right ventricular trabeculations. Furthermore, the posterior wall is difficult to measure due to many trabeculations in the basal part of the ventricle and this leads to possibly incorrect measurement. Also, the LV dimension was slightly larger with M-mode measurement. 2D imaging on the left side can achieve a proper geometric cut and slightly smaller wall thickness measurements. The yellow dotted line on the left image has been added to make the M-mode cut line more clearly visible
Reference limits for left ventricular measurements
| Variable | Males | Females | ||||
|---|---|---|---|---|---|---|
| Abnormal | Moderately abnormal | Severely abnormal | Abnormal | Moderately abnormal | Severely abnormal | |
| LV dimensions | ||||||
| 2D method | ||||||
| LV end-diastolic diameter (mm) | > 56 | > 60 | > 63 | > 51 | > 56 | > 58 |
| LV end-diastolic diameter, BSA (mm/m2) | > 28 | > 30 | > 31 | > 30 | > 31 | > 32 |
| M-mode method | ||||||
| LV end-diastolic diameter (mm) | > 60 | > 64 | > 66 | > 55 | > 59 | > 63 |
| VLV end-diastolic diameter, BSA (mm/m2) | > 31 | > 32 | > 33 | > 32 | > 33 | > 34 |
| LV end-systolic diameter (mm) | > 40 | > 44 | > 49 | > 36 | > 39 | > 41 |
| LV end-systolic diameter, BSA (mm/m2) | > 20 | > 21 | > 23 | > 21 | (> 21)a | (> 23)a |
| LV mass and wall thickness | ||||||
| 2D method | ||||||
| Interventricular septum (mm) | > 11.5 | > 14.0 | > 15.0 | > 10.3 | > 12.3 | > 13.3 |
| Posterior wall (mm) | > 10.7 | > 12.3 | > 13.0 | > 9.3 | > 11.0 | > 11.7 |
| LV mass, BSA (g/m2) | > 107 | > 130 | > 138 | > 82 | > 111 | > 128 |
| M-mode method | ||||||
| Interventricular septum (mm) | > 12.7 | > 14.3 | > 15.0 | > 11.0 | > 12.7 | > 13.7 |
| Posterior wall (mm) | > 11.0 | > 13.3 | > 14.0 | > 9.7 | > 11.5 | > 12.3 |
| LV mass, BSA (g/m2) | > 122 | > 147 | > 167 | > 104 | > 129 | > 141 |
| LV mass, height2.7 (g/m) | > 53 | > 68 | > 76 | > 47 | > 69 | > 76 |
| LV volumes and function | ||||||
| LV end-diastolic volume (ml) | > 150 | > 181 | > 205 | > 109 | > 136 | > 157 |
| LV end-diastolic volume, BSA (ml/m2) | > 73 | > 85 | > 94 | > 63 | > 73 | > 85 |
| LV end-systolic volume (ml) | > 69 | > 81 | > 99 | > 44 | > 56 | > 71 |
| LV end-systolic volume, BSA (ml/m2) | > 33 | > 39 | > 46 | > 25 | > 30 | > 37 |
| LV ejection fraction (%) | < 50 | < 46 | < 42 | < 53 | < 50 | < 47 |
| Mitral septal s’ (cm/s) | < 6.0 | < 5.0 | < 4.3 | < 6.0 | < 5.0 | < 4.3 |
| Mitral lateral s’ (cm/s) | < 6.3 | < 5.0 | < 4.3 | < 6.0 | < 5.3 | < 5.0 |
Mildly abnormal is defined as >95th or < 5th percentile of the healthy subset, moderately abnormal as > 97.5th or < 2.5th percentile and severely abnormal as >99th or < 1st percentile of the whole sample
BSA body surface area, LV left ventricle
aNot recommended due to negligible difference between the healthy subset and general population, see Limitations
Reference limits for left atrium, right chambers and aorta
| Variable | Males | Females | ||||
|---|---|---|---|---|---|---|
| Abnormal | Moderately abnormal | Severely abnormal | Abnormal | Moderately abnormal | Severely abnormal | |
| Left atrium | ||||||
| LA diameter M-mode (mm) | > 46 | > 53 | > 56 | > 41 | > 48 | > 51 |
| LA diameter M-mode, BSA (mm/m2) | > 23 | > 25 | > 27 | > 24 | > 26 | > 27 |
| LA vertical diameter (mm) | > 61 | > 67 | > 71 | > 56 | > 61 | > 63 |
| LA horizontal diameter (mm) | > 48 | > 52 | > 54 | > 46 | > 50 | > 54 |
| LA volume (ml) | > 86 | > 108 | > 123 | > 70 | > 90 | > 105 |
| LA volume, BSA (ml/m2) | > 42 | > 52 | > 59 | > 40 | > 48 | > 53 |
| Right ventricle | ||||||
| RV basal diameter (mm) | > 46 | > 47 | > 48 | > 39 | > 42 | > 43 |
| RV basal diameter, BSA (mm/m2) | > 23 | (> 23)a | (> 24)a | > 23 | (> 24)a | (> 24)a |
| Tricuspid s’ (m/s) | < 9.0 | < 8.0 | < 7.0 | < 9.0 | < 8.0 | < 7.7 |
| TAPSE (mm) | < 19 | < 17 | < 15 | < 19 | < 18 | < 17 |
| Right atrium | ||||||
| RA vertical diameter (mm) | > 57 | > 61 | > 65 | > 51 | > 56 | > 58 |
| RA horizontal diameter (mm) | > 50 | (> 50)a | (> 53)a | > 42 | > 45 | > 47 |
| RA vertical diameter, BSA (mm/m2) | > 28 | > 30 | > 32 | > 30 | > 31 | > 33 |
| RA horizontal diameter, BSA (mm/m2) | > 25 | (> 25)a | (> 26)a | > 25 | > 26 | > 27 |
| Aorta | ||||||
| Aortic root (mm) | > 40 | > 42 | > 43 | > 34 | > 36 | > 37 |
| Aortic root, BSA (mm/m2) | > 19 | > 20 | > 21 | > 20 | > 21 | > 22 |
Mildly abnormal is defined as >95th or < 5th percentile of the healthy subset, moderately abnormal as > 97.5th or < 2.5th percentile and severely abnormal as >99th or < 1st percentile of the whole sample
BSA body surface area, LA left atrium, RA right atrium, RV right ventricle, TAPSE tricuspid annular systolic plane excursion
aNot recommended due to negligible difference between the healthy subset and general population, see Limitations